Tenaya Therapeutics Inc.
TNYA | NASDAQ
$0.67
-$0.01 (-1.37%)
At close: Sep 21, 2026, 4:00 PM ET
$0.68
+$0.01 (+0.75%)
Pre-market:
Sep 22, 2026, 8:17 AM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 8.44M | 8.47M | 8.69M | 8.71M | 4.03M | 2.48M |
Gross Profit | -8.44M | -8.47M | -8.69M | -8.71M | -4.03M | -2.48M |
Operating Income | -93.33M | -115.95M | -131.19M | -125.62M | -72.81M | -38.91M |
Interest Income | 2.68M | 4.74M | 7.06M | 1.95M | 108K | 87K |
Pretax Income | -90.6M | -111.13M | -124.08M | -123.67M | -72.72M | -38.4M |
Net Income | -90.6M | -111.13M | -124.08M | -123.67M | -72.72M | -38.4M |
Selling & General & Admin | 24.72M | 20.74M | 24.47M | 22.37M | 14.39M | 5.33M |
Research & Development | 68.61M | 86.74M | 98.04M | 94.54M | 54.39M | 31.1M |
Other Expenses | -8.44M | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 84.9M | 107.48M | 122.51M | 116.91M | 68.78M | 36.43M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 93.33M | 115.95M | 131.19M | 125.62M | 72.81M | 38.91M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 152.97M | 84.82M | 73.79M | 44.82M | 41.29M | 41.12M |
Shares Outstanding (Diluted) | 152.97M | 84.82M | 73.79M | 44.82M | 41.29M | 41.12M |
EPS (Basic) | -0.59 | -1.31 | -1.68 | -2.76 | -1.69 | -0.93 |
EPS (Diluted) | -0.59 | -1.31 | -1.68 | -2.76 | -1.69 | -0.93 |
EBITDA | -82.16M | -102.66M | -115.4M | -114.95M | -68.7M | -35.91M |
EBIT | -90.6M | -111.13M | -124.08M | -123.67M | -72.72M | -38.4M |
Depreciation & Amortization | 8.44M | 8.47M | 8.69M | 8.71M | 4.03M | 2.48M |
Add to Watchlist
Select watchlists to add or remove TNYA